Thrombosis and Haemostasis

Article	Citations
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	122
	116
	104
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	103
High anti-ADAMTS13 IgG Levels after Plasma Exchange Predict Delayed ADAMTS13 Normalization in Immune-mediated Thrombotic Thrombocytopenic Purpura	100
Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	83
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	70
	69
Staying on Track: Collagen Fibers Orientation Strongly Affects Thrombi Formation at High Shear	55
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2	54
Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation	53
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	47
Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands—Results of the TERA Case-Control Study	46
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	35
Transient Platelet Hyporesponsiveness in Nonischemic Arrhythmogenic Cardiac Arrest After Achieving Restoration of Spontaneous Circulation in Pigs	32
Predictors, Incidence, and Proximal Extension Rate of Distal Deep Vein Thrombosis in Internal Medicine Wards: Insights from the AURELIO Study	30
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	30
	30
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	27
	27
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	25
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	25
Reflections on World Thrombosis Day 2024	23
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	23
Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study	23

Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	23
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	22
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	22
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	22
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	21
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	21
Perioperative Management of Patients Receiving Factor XI Inhibitors	21
De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study	21
Longitudinal In Vivo Monitoring of Atheroprogression in Hypercholesterolemic Mice Using Photoacoustic Imaging	19
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	19
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	19
Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study	19
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	19
Are More Patients with Thromboembolic Disease Dying Now Than Before?	19
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	19
Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders	18
Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model	18
Approach to Optimizing Tranexamic Acid Use in Trauma: Potential Utilization of Trauma Phenotypes	17
Enhancing Pulmonary Embolism Risk Stratification: The National Early Warning Score and Its Integration into the European Society of Cardiology Classification	17
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials	17
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia	16
Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction	15
Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1	15
Open Issues in the Choice and Management of Direct Oral Anticoagulants in Patients with Cancer-Related Venous Thromboembolism	15
Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists—a Nationwide Linked-data Dutch Study	15
Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis	15
Dual Antiplatelet Therapy or Dual Pathway Inhibition	15
Optimal Detection of Atrial Fibrillation in Transient Ischaemic Attack: Rationale and design of the ODEA-TIA trial	14
Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding	14
Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries	14
Sensitivity to Aortic Rupture in Hereditary Aortic Diseases	14
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis	14
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level	14
	14
Novel Immunochromatographic Test for Anti-factor XIII B Subunit Autoantibodies to Diagnose Autoimmune Acquired Factor XIII Deficiency	13
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production	13
N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity	13
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice	13
The Prognostic Value of the Age–D-Dimer–Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention	13
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients	13
Transfer RNAs are Linked to Ischemic Stroke and Major Bleeding in Patients with End-Stage Kidney Disease	13
Pulmonary Thromboembolism after Catheter Ablation of Cardiac Arrhythmias	13
Emerging Thrombotic Disorders Associated with Virus-Based Innovative Therapies: From VITT to AAV Gene Therapy–Related Thrombotic Microangiopathy	13
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases	12
Thrombosis and Haemostasis 2022 Editors' Choice Papers	12
Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study	12
	12
Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease	12
CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear	12
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both?	12

Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	12
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation	11
	11
Characterization of Arteriovenous Thrombus Formation and Propagation in a Mouse Arteriovenous Fistula Model	11
Extravascular Binding of Coagulation Factor IX Gives Hemostasis a Boost	11
In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19	11
Cryofibrinogen—Characteristics and Association with Cryoglobulin: A Retrospective Study Out of a Series of 1,712 Samples over 7 Years	11
Platelet-Leukocyte Aggregates: Targeting the Crosstalk	11
Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation	11
Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	11
Risk Factors for Venous Thromboembolism in Women of Childbearing Age	11
Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention	11
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer	11
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia	10
Lymphoblasts Express Hemostatic Factors: A Mechanism for Hypercoagulability in Pediatric Acute Lymphoblastic Leukemia	10
	10
Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does It Mean for Clinical Practice?	10
Brisk Walking Pace Offsets Venous Thromboembolism Risk Equivalent to Established Monogenic Mutations	10
	10
Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII	10
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together	10
Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin	9
Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study	9
Bacterial-Type Long-Chain Polyphosphates Bind Human Proteins in the Phosphatidylinositol Signaling Pathway	9
Digital Twins for Predictive Modelling of Thrombosis and Stroke Risk: Current Approaches and Future Directions	9
Physical and Mechanobiological Basis of Biological Functions of Platelets	9
Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters	9
Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort	9
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis	9
Personalized Medicine, Public Health and Patient-Centred Aspects in the Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation (PRESTIGE-AF) Project	9
Activation of the Acute-Phase Response in Hemophilia	9
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?	9
Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study	8
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	8
Unveiling the Genetic Landscape of Inherited Primary Hemostasis Disorders by Whole-Exome Sequencing: Insights from a Multicenter Study	8
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	8
Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis	8
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)	8
	8
High-Resolution Spatial Profiling Unveils Cellular Heterogeneity in Murine Atherosclerosis	8
Ischemic Stroke Burden Attributable to Household Air Pollution in WHO Regions from 1990 to 2021	8
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	8
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	8
	8
Human Platelets Internalize Pregnancy-Specific Glycoprotein-1 (PSG1)	8
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	8
The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction	8
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	8
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	8
Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype	8
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study)	8
Reply to the Comment: Revisiting Platelet-Associated Tissue Factor: Methodological Concerns in Flow Cytometry Detection: A Letter to the Editor	7
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	7
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	7
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	7
U-shaped Association of Third-trimester Serum Uric Acid with Postpartum Hemorrhage: Statistical Mediation Effects of Hemoglobin, Fibrinogen, and D-dimer—A Multicenter Cohort Study	7
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals	7
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	7
	7
Title: Association of Anisocytosis with Platelet-Rich Thrombi and Stroke Recurrence in Patients Undergoing Thrombectomy	7
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	7
Utility of Sepsis-induced Coagulopathy Among Disseminated Intravascular Coagulation Diagnostic Criteria: A Multicenter Retrospective Validation Study	7
Educational Attainment, Obesity, and Venous Thromboembolism. Is Only Matter of Weight?	7
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	7
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	7
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	7
	7
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	7
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	7
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	7
Racial Differences in Bleeding Risks among Patients with Atrial Fibrillation: An Ecological Epidemiological Study Comparing Korea and UK Population	7
Navigating Anticoagulation in Ischemic Left Ventricular Aneurysms: Lessons from Cardiac Magnetic Resonance Imaging	7
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	7
	7
Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases	6
Free Fatty Acids Link Residual Lipid and Thrombotic Risk via Impairment of Aspirin Antiplatelet Effects	6
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	6
The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease	6
De-escalation of DAPT—A Potential Strategy for Treating Ticagrelor-Related Dyspnea?	6
	6

	6
Hyperfibrinolysis is Associated with Complement Activation Following Trauma	6
Trypsin Activates Human Platelets via Proteolytic Cleavage of Protease-Activated Receptor 4	6
Pharmacological Inhibition of Glycoprotein VI- and Integrin α2β1-Induced Thrombus Formation Modulated by the Collagen Type	6
	6
Platelet Aggregation Is Not Altered in Men with Aortic Aneurysms	6
Blood Levels and Composition of Leukocyte–Platelet Aggregates in Inflammatory Diseases of Various Etiologies	6
Thrombosis Caused by Factor XI Gly397Ser Mutation with Enhanced Procoagulant Activity	6
DOACs for Superficial Vein Thrombosis: Risks of Pooling RCTs and Observational Studies in Comparative Effectiveness	6
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study	6
	6
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Su	6
Structural Conformation and the Binding of Factor VIII R2159C (FVIII-Ise) Mutated in the C1 Domain to Phospholipid	5
Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery	5
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis	5
An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary	5
Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia	5
Prognostic Value of BARC-defined Bleeding in East Asian Acute Myocardial Infarction Patients: Evidence from Multicentre Registries in Korea and Japan	5
Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk	5
Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis	5
Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy	5
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis	5
Major Bleeding Risk During Concomitant Use of Antiarrhythmic Drugs and Oral Factor Xa Inhibitors: A Nationwide Self-Controlled Case Series Study	5
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	5
CXCL2 Mediates Lactate Secretion and Promotes Aortic Dissection Formation through the p38/JNK/C-myc Pathways	5
Practical Machine Learning Model for Early and Accurate Prediction of Disseminated Intravascular Coagulation Before Its Progression to an OVERT Stage	5
Performance of Bleeding Risk Scores for Major Bleeding in Anticoagulated Patients with Pulmonary Embolism: Insights from the CURES Registry-2	5
	5
A Happy New Year 2024 from Thrombosis and Haemostasis!	5
Pleiotrophin Promotes Megakaryocyte Differentiation and Thrombocytopoiesis by Regulating PTPRZ1–Fyn–Akt Signaling in Thrombocytopenia after Allo-HSCT	5
C-reactive Protein, Genetic Susceptibility, and the Long-Term Risk of Venous Thromboembolism in Patients with Past Cancer	5
Concomitant Use of Selective Serotonin Reuptake Inhibitors and Oral Anticoagulants and Risk of Major Bleeding: A Systematic Review and Meta-analysis	5
Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism	5
Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study	5
	5
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial	5
Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices	5
Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes	5
Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII	5
Factor XIII-A Transglutaminase Contributes to Neutrophil Extracellular Trap (NET)-mediated Fibrin(ogen) Network Formation and Crosslinking	5
Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency	5
Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A	4
Left Atrial Spontaneous Echo Contrast: Pathogenesis, Detection, and Modelling	4
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin	4
An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency	4
Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism	4
Field Study and Correlative Studies of Factor IX Variant FIX-R338L in Participants Treated with Fidanacogene Elaparvovec	4
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review	4
Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction	4
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate	4
	4
Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19	4
DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study	4
Identification of Factor XIII β-Sandwich Residues Mediating Glutamine Substrate Binding and Activation Peptide Cleavage	4
	4
Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis	4
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin	4
Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	4
	4
Venous Thromboembolism Outcomes Among Cancer and Non-cancer Patients Managed with Patient-centric Guideline-driven Protocol	4
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF	4
Edoxaban Population Pharmacokinetics in Chinese Patients with Nonvalvular Atrial Fibrillation: Model-Informed Dose Adjustment	4
	4
Reversible Thrombocytopenia of Functional Platelets after Nose-Horned Viper Envenomation is Induced by a Snaclec	4
Binding Promiscuity of Therapeutic Factor VIII	4
Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials	4
Elevated Protein S Provides Evidence against Hypoxia-Induced Hypercoagulation in Tibetan Highlanders with PHD2D4E;C127S Polymorphisms	4
Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?	4
	4
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study	4
Knockdown of tmem183a in Zebrafish Causes Thrombocytopenia and Reduces Coagulation Factors, Disrupting Hemostasis	4
Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects	4
D-β-Hydroxybutyrate Dehydrogenase Mitigates Diabetes-Induced Atherosclerosis through the Activation of Nrf2	4
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study	4
Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study	4
Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations	4
Stroke in Mechanical Circulatory Supported Cardiogenic Shock	4
Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue	4
Stability of Rivaroxaban and Apixaban Anti-Xa Activities in Whole Blood Samples: A French Bicentric Study	4
P2Y12 Inhibition Suppresses Proinflammatory Platelet–Monocyte Interactions	4
Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence	4
Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	3
Increased Cancer Risk in Patients with Kidney Disease and Venous Thromboembolism: A Population-Based Cohort Study	3
Optimizing Use of High-Sensitivity Troponin for Risk-Stratification of Acute Pulmonary Embolism	3
	3
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway	3
Safety of Prothrombin Complex Concentrate for Emergency Surgery According to the Oral Factor Xa Inhibitor Level	3
ADAMTS13 or Caplacizumab Reduces the Accumulation of Neutrophil Extracellular Traps and Thrombus in Whole Blood of COVID-19 Patients under Flow	3
Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis	3
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study	3
Catheter-Directed Thrombolysis for Deep Vein Thrombosis: Serving at Break Point	3
Statin Treatment Is Associated with Alterations in the Platelet Lipidome	3
Strategic Lowering of LDL-Cholesterol Post Ischemic Stroke: Identifying Optimal Targets, Timing, and Therapeutic Approaches	3
Welcoming 2025—A Year of Collaboration and Progress	3
Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan	3